BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 36523635)

  • 1. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.
    Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R
    Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression.
    Kong X; Zhang Y; Xiang L; You Y; Duan Y; Zhao Y; Li S; Wu R; Zhang J; Zhou L; Duan L
    J Exp Clin Cancer Res; 2023 Sep; 42(1):236. PubMed ID: 37684625
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances on the treatment of
    Wang H; Hou X; Liu J; Yang C
    Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
    Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kim HS; Kim CG; Kim WK; Kim KA; Yoo J; Min BS; Paik S; Shin SJ; Lee H; Lee K; Kim H; Shin EC; Kim TM; Ahn JB
    Front Cell Infect Microbiol; 2023; 13():1101291. PubMed ID: 36960042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbial metabolite formate exacerbates colorectal cancer progression.
    Ternes D; Tsenkova M; Pozdeev VI; Meyers M; Koncina E; Atatri S; Schmitz M; Karta J; Schmoetten M; Heinken A; Rodriguez F; Delbrouck C; Gaigneaux A; Ginolhac A; Nguyen TTD; Grandmougin L; Frachet-Bour A; Martin-Gallausiaux C; Pacheco M; Neuberger-Castillo L; Miranda P; Zuegel N; Ferrand JY; Gantenbein M; Sauter T; Slade DJ; Thiele I; Meiser J; Haan S; Wilmes P; Letellier E
    Nat Metab; 2022 Apr; 4(4):458-475. PubMed ID: 35437333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
    Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.
    Chen T; Li Q; Wu J; Wu Y; Peng W; Li H; Wang J; Tang X; Peng Y; Fu X
    Cancer Immunol Immunother; 2018 Oct; 67(10):1635-1646. PubMed ID: 30121899
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang M; Wang Z; Lessing DJ; Guo M; Chu W
    Microbiol Spectr; 2023 Dec; 11(6):e0229223. PubMed ID: 37889013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
    Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients.
    Pang SW; Armon S; Chook JB; Chew J; Peh KB; Lim WW; Peh SC; Teow SY
    Mol Biol Rep; 2024 Jan; 51(1):124. PubMed ID: 38227097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
    Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
    Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.